Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 06 05 2020
accepted: 02 10 2020
entrez: 13 11 2020
pubmed: 14 11 2020
medline: 24 11 2020
Statut: epublish

Résumé

This study aims to describe the epidemiology of COVID-19 patients in a Swiss university hospital. This retrospective observational study included all adult patients hospitalized with a laboratory confirmed SARS-CoV-2 infection from March 1 to March 25, 2020. We extracted data from electronic health records. The primary outcome was the need to mechanical ventilation at day 14. We used multivariate logistic regression to identify risk factors for mechanical ventilation. Follow-up was of at least 14 days. 145 patients were included in the multivariate model, of whom 36 (24.8%) needed mechanical ventilation at 14 days. The median time from symptoms onset to mechanical ventilation was 9·5 days (IQR 7.00, 12.75). Multivariable regression showed increased odds of mechanical ventilation with age (OR 1.09 per year, 95% CI 1.03-1.16, p = 0.002), in males (OR 6.99, 95% CI 1.68-29.03, p = 0.007), in patients who presented with a qSOFA score ≥2 (OR 7.24, 95% CI 1.64-32.03, p = 0.009), with bilateral infiltrate (OR 18.92, 3.94-98.23, p<0.001) or with a CRP of 40 mg/l or greater (OR 5.44, 1.18-25.25; p = 0.030) on admission. Patients with more than seven days of symptoms on admission had decreased odds of mechanical ventilation (0.087, 95% CI 0.02-0.38, p = 0.001). This study gives some insight in the epidemiology and clinical course of patients admitted in a European tertiary hospital with SARS-CoV-2 infection. Age, male sex, high qSOFA score, CRP of 40 mg/l or greater and a bilateral radiological infiltrate could help clinicians identify patients at high risk for mechanical ventilation.

Sections du résumé

BACKGROUND
This study aims to describe the epidemiology of COVID-19 patients in a Swiss university hospital.
METHODS
This retrospective observational study included all adult patients hospitalized with a laboratory confirmed SARS-CoV-2 infection from March 1 to March 25, 2020. We extracted data from electronic health records. The primary outcome was the need to mechanical ventilation at day 14. We used multivariate logistic regression to identify risk factors for mechanical ventilation. Follow-up was of at least 14 days.
RESULTS
145 patients were included in the multivariate model, of whom 36 (24.8%) needed mechanical ventilation at 14 days. The median time from symptoms onset to mechanical ventilation was 9·5 days (IQR 7.00, 12.75). Multivariable regression showed increased odds of mechanical ventilation with age (OR 1.09 per year, 95% CI 1.03-1.16, p = 0.002), in males (OR 6.99, 95% CI 1.68-29.03, p = 0.007), in patients who presented with a qSOFA score ≥2 (OR 7.24, 95% CI 1.64-32.03, p = 0.009), with bilateral infiltrate (OR 18.92, 3.94-98.23, p<0.001) or with a CRP of 40 mg/l or greater (OR 5.44, 1.18-25.25; p = 0.030) on admission. Patients with more than seven days of symptoms on admission had decreased odds of mechanical ventilation (0.087, 95% CI 0.02-0.38, p = 0.001).
CONCLUSIONS
This study gives some insight in the epidemiology and clinical course of patients admitted in a European tertiary hospital with SARS-CoV-2 infection. Age, male sex, high qSOFA score, CRP of 40 mg/l or greater and a bilateral radiological infiltrate could help clinicians identify patients at high risk for mechanical ventilation.

Identifiants

pubmed: 33186355
doi: 10.1371/journal.pone.0240781
pii: PONE-D-20-13349
pmc: PMC7665644
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0240781

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
J Intern Med. 2006 Jul;260(1):93-101
pubmed: 16789984
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Stat Methods Med Res. 2019 Aug;28(8):2455-2474
pubmed: 29966490
Clin Infect Dis. 2020 Jul 28;71(15):833-840
pubmed: 32296824
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372754
Clin Microbiol Infect. 2018 Nov;24(11):1123-1129
pubmed: 29605565
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Medicine (Baltimore). 2019 Jun;98(23):e15966
pubmed: 31169726
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379
pubmed: 32242738
Lancet Respir Med. 2020 Sep;8(9):853-862
pubmed: 32735842
Crit Care. 2020 Mar 18;24(1):108
pubmed: 32188484
Crit Care Resusc. 2020 Apr 06;22(2):119-125
pubmed: 32248675
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Crit Care. 2020 Jun 16;24(1):348
pubmed: 32546258
Nature. 2020 Aug 26;:
pubmed: 32846427
Eur J Intern Med. 2020 Apr;74:86-91
pubmed: 31899057
Kidney Int Suppl (2011). 2012 Mar;2(1):19-36
pubmed: 25018918
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
BMJ. 2012 Aug 08;345:e5310
pubmed: 22875955

Auteurs

Jean Regina (J)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Matthaios Papadimitriou-Olivgeris (M)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Service of Hospital Preventive Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Raphaël Burger (R)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Service of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Marie-Annick Le Pogam (MA)

Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Tapio Niemi (T)

Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Paraskevas Filippidis (P)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Jonathan Tschopp (J)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Florian Desgranges (F)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Benjamin Viala (B)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Eleftheria Kampouri (E)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Laurence Rochat (L)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

David Haefliger (D)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Mehdi Belkoniene (M)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Service of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Carlos Fidalgo (C)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Service of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Antonios Kritikos (A)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Katia Jaton (K)

Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Laurence Senn (L)

Service of Hospital Preventive Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Pierre-Alexandre Bart (PA)

Service of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Jean-Luc Pagani (JL)

Service of Intensive Care, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Oriol Manuel (O)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Loïc Lhopitallier (L)

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH